M Pfreundschuh

858 total citations
33 papers, 489 citations indexed

About

M Pfreundschuh is a scholar working on Pathology and Forensic Medicine, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, M Pfreundschuh has authored 33 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pathology and Forensic Medicine, 10 papers in Genetics and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in M Pfreundschuh's work include Lymphoma Diagnosis and Treatment (18 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Lung Cancer Treatments and Mutations (7 papers). M Pfreundschuh is often cited by papers focused on Lymphoma Diagnosis and Treatment (18 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Lung Cancer Treatments and Mutations (7 papers). M Pfreundschuh collaborates with scholars based in Germany, Switzerland and Australia. M Pfreundschuh's co-authors include Christoph Renner, Gerhard Held, Marek Trněný, Markus Loeffler, Steven R. Bauer, Stefan Bauer, Ruth Pettengell, Pier Luigi Zinzani, Bertrand Coiffier and Laurie H. Sehn and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

M Pfreundschuh

29 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Pfreundschuh Germany 13 235 219 179 94 68 33 489
Therese White United States 11 229 1.0× 195 0.9× 171 1.0× 169 1.8× 125 1.8× 22 557
Aneal S. Masih United States 12 345 1.5× 246 1.1× 118 0.7× 125 1.3× 53 0.8× 19 544
Andreas Himmelmann Switzerland 10 267 1.1× 186 0.8× 211 1.2× 158 1.7× 125 1.8× 26 600
T Papadaki Greece 9 262 1.1× 160 0.7× 144 0.8× 208 2.2× 33 0.5× 13 442
S. Poppema Netherlands 13 448 1.9× 268 1.2× 262 1.5× 186 2.0× 74 1.1× 15 695
H Stein Germany 7 222 0.9× 136 0.6× 137 0.8× 105 1.1× 80 1.2× 15 380
Vera Vanhentenrijk Belgium 12 374 1.6× 241 1.1× 143 0.8× 219 2.3× 144 2.1× 13 571
Emanuela Carlotti United Kingdom 10 326 1.4× 230 1.1× 171 1.0× 164 1.7× 119 1.8× 20 579
Volker Diehl Germany 14 179 0.8× 202 0.9× 164 0.9× 146 1.6× 117 1.7× 23 501
P. Korkolopoulou Greece 12 121 0.5× 243 1.1× 208 1.2× 119 1.3× 177 2.6× 19 632

Countries citing papers authored by M Pfreundschuh

Since Specialization
Citations

This map shows the geographic impact of M Pfreundschuh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Pfreundschuh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Pfreundschuh more than expected).

Fields of papers citing papers by M Pfreundschuh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Pfreundschuh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Pfreundschuh. The network helps show where M Pfreundschuh may publish in the future.

Co-authorship network of co-authors of M Pfreundschuh

This figure shows the co-authorship network connecting the top 25 collaborators of M Pfreundschuh. A scholar is included among the top collaborators of M Pfreundschuh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Pfreundschuh. M Pfreundschuh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hutchings, Martin, Marco Ladetto, Christian Buske, et al.. (2018). ESMO Consensus Conference on malignant lymphoma: management of ‘ultra-high-risk’ patients. Annals of Oncology. 29(8). 1687–1700. 16 indexed citations
2.
Pfreundschuh, M, Konstantinos Christofyllakis, Bettina Altmann, et al.. (2017). Radiotherapy to bulky disease PET-negative after immunochemotherapy can be spared in elderly DLBCL patients: results of a planned interim analysis of the first 187 patients with bulky disease treated in the OPTIMAL > 60 study of the DSHNHL.
3.
Seymour, John F., M Pfreundschuh, Marek Trněný, et al.. (2014). R-CHOP with or without bevacizumab in patients with previously untreated diffuse large B-cell lymphoma: final MAIN study outcomes. Haematologica. 99(8). 1343–1349. 76 indexed citations
4.
Simon, Pierre, Claudia Pfoehler, Raoul Bergner, et al.. (2012). Swollen joint count in psoriatic arthritis is associated with progressive radiological damage in hands and feet.. PubMed. 30(1). 45–50. 20 indexed citations
5.
Pfreundschuh, M. (2009). Radiotherapy in the rituximab era: still a place?. 3(3). 1 indexed citations
6.
Koch, Bernhard A., et al.. (2008). Diagnose- und Klassifikationskriterien in der Rheumatologie: Kollagenosen. DMW - Deutsche Medizinische Wochenschrift. 121(28/29). 913–918.
7.
8.
Pfreundschuh, M, Samira Zeynalova, W. E. Berdel, et al.. (2006). Dose-escalated CHOP plus etoposide (Hi-CHOEP) is not superior to base-line CHOEP in young good-prognosis patients with aggressive lymphoma: Results of a randomized DSHNHL trial. Journal of Clinical Oncology. 24(18_suppl). 7513–7513. 4 indexed citations
9.
Schlapschy, Martin, H.‐J. Gruber, Oliver Gresch, et al.. (2005). Functional humanization of an anti-CD30 Fab fragment for the immunotherapy of Hodgkin's lymphoma using an in vitro evolution approach. Protein Engineering Design and Selection. 17(12). 847–860. 24 indexed citations
10.
11.
12.
Tesch, Hans, M. Sieber, Jens Ulrich Rüffer, et al.. (1999). 2 Cycles of ABVD Plus Radiotherapy Is More Effective Than Radiotherapy Alone in Early Stage HD—Interim Ahan Radiotherapy Alone in Early Stage HD—Interim Analysis of the HD7 Trial of the GHSG Clinic of Internal Medicine I University of Cologne/Germany. 1 indexed citations
13.
Braun, Christoph, et al.. (1996). Ulnar deviation is not always rheumatoid.. Annals of the Rheumatic Diseases. 55(11). 786–788. 1 indexed citations
14.
15.
Tesch, Hans, Andreas Engert, B. Lathan, et al.. (1993). Therapy of Hodgkin’s Disease. Oncology Research and Treatment. 16(6). 407–415. 2 indexed citations
16.
Gause, Angela, et al.. (1991). Clinical significance of soluble CD30 antigen in the sera of patients with untreated Hodgkin's disease. Blood. 77(9). 1983–1988. 3 indexed citations
17.
Schaadt, M., et al.. (1990). Phase II study of recombinant human tumor necrosis factor in colorectal carcinoma.. PubMed. 9(2). 247–50. 14 indexed citations
18.
Pfreundschuh, M. (1988). [Update oncology '88: the age of biological factors].. PubMed. 83(16). 532–8. 1 indexed citations
19.
Schmoll, Hans‐Joachim, Ingrid Schübert, Gottfried Dölken, et al.. (1987). Disseminated testicular cancer with bulky disease: results of a phase‐II study with cisplatin ultra high dose/VP‐16/bleomycin. International Journal of Andrology. 10(1). 311–317. 12 indexed citations
20.
Pfreundschuh, M. (1987). [Current status and perspectives of immunodiagnosis and immunotherapy in oncology].. PubMed. 82(9). 320–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Therese White Breakdown of academic impact, for papers by Aneal S. Masih Breakdown of academic impact, for papers by Andreas Himmelmann Breakdown of academic impact, for papers by T Papadaki Breakdown of academic impact, for papers by S. Poppema Breakdown of academic impact, for papers by H Stein Breakdown of academic impact, for papers by Vera Vanhentenrijk Breakdown of academic impact, for papers by Emanuela Carlotti Breakdown of academic impact, for papers by Volker Diehl Breakdown of academic impact, for papers by P. Korkolopoulou
Rankless by CCL
2026